Otsuka, Lundbeck gain FDA nod for longer-acting version of schizophrenia drug Abilify
28th April 2023 Uncategorised 0 Otsuka, Lundbeck gain FDA nod for longer-acting version of schizophrenia drug Abilify
kdunleavy
Fri, 04/28/2023 – 10:29
More: Otsuka, Lundbeck gain FDA nod for longer-acting version of schizophrenia drug Abilify
Source: fierce